Efficacy and effectiveness of mefloquine and artesunate combination therapy for uncomplicated Plasmodium falciparum malaria in the Peruvian Amazon

American Journal of Tropical Medicine and Hygiene

Volumn 85, Issue 3, 2011, Pages 573-578

  De Oliveira, Alexandre Macedo ^a   Chavez, Jorge ^b   Ponce De Leon, Gabriel ^a   Durand, Salomon ^c   Arrospide, Nancy ^d   Roberts, Jacquelin ^a   Cabezas, Cesar ^d   Marquino, Wilmer ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSIDAD CÉSAR VALLEJO   (Peru)

^c Peru   (Peru)

^d INSTITUTO NACIONAL DE SALUD   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; DIMENHYDRINATE; MEFLOQUINE; PARACETAMOL;

ADOLESCENT; ADULT; AGED; ARTICLE; AXILLA TEMPERATURE; CHILD; DRUG EFFICACY; DRUG INDUCED HEADACHE; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NAUSEA; PARASITEMIA; PERU; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STOMACH PAIN; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; DIRECTLY OBSERVED THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PERU; PLASMODIUM FALCIPARUM; YOUNG ADULT;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 80052803263     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.11-0250     Document Type: Article

References (29)

1. Magill AJ, Zegarra J, Garcia C, Marquino W, Ruebush TK II, 2004. Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru. Rev Soc Bras Med Trop 37: 279-281. (Pubitemid 38797094)
2. Marquino W, Huilca M, Calampa C, Falconi E, Cabezas C, Naupay R, Ruebush TK II, 2003. Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru. Am J Trop Med Hyg 68: 608-612. (Pubitemid 38240503)
3. Williams HA, Vincent-Mark A, Herrera Y, Chang OJ, 2009. A retrospective analysis of the change in anti-malarial treatment policy: Peru. Malar J 8: 85.
4. Gbotosho GO, Happi CT, Ganiyu A, Ogundahunsi OA, Sowunmi A, Oduola AM, 2009. Potential contribution of prescription practices to the emergence and spread of chloroquine resistance in south-west Nigeria: caution in the use of artemisinin combination therapy. Malar J 8: 313.
5. Durand SMW, Ruebush TK, Cairo J, Carrion R, Quintana F, Bellina C, Rodriguez H, Utz GC, 2004. Assessment of the Implementation of Mefloquine-Artesunate and Sulfadoxine-Pyrimethamine-Artesunate Combination Therapies for Plasmodium falciparum Malaria in Peru. American Society of Tropical Medicine and Hygiene Annual Meeting, Miami, Florida.
6. Sistema de Vigilancia de la Resistencia a Medicamentos Antimalaricos en el Peru. Lima, Peru: Instituto Nacional de Salud.
7. Boletin Epidemiologico. Semana Epidemiologica No. 51. Lima, Peru: Instituto Nacional de Salud.
8. Pan American Health Organization, 1998. Evaluacion de la Eficacia Terapeutica de Los Medicamentos para el Tratamiento del Paludismo por Plasmodium falciparum sin Ccomplicaciones en las Americas. Washington, DC: Pan American Health Organization.
9. World Health Organization, 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated falciparum Malaria. Geneva: World Health Organization.
10. World Health Organization, 2009. Methods for Surveillance of Antimalarial Drug Efficacy. Geneva: World Health Organization.
11. McCollum AM, Mueller K, Villegas L, Udhayakumar V, Escalante AA, 2007. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxinepyrimethamine resistance in a low-transmission area in South America. Antimicrob Agents Chemother 51: 2085-2091. (Pubitemid 46903098)
12. Anderson TJ, Su XZ, Bockarie M, Lagog M, Day KP, 1999. Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples. Parasitology 119: 113-125. (Pubitemid 29381128)
13. Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WR, Nosten F, White NJ, 2010. In vivo parasitological measures of artemisinin susceptibility. J Infect Dis 201: 570-579.
14. Gutman J, Green M, Durand S, Rojas OV, Ganguly B, Quezada WM, Utz GC, Slutsker L, Ruebush TK II, Bacon DJ, 2009. Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria. Malar J 8: 58.
15. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ, 2000. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356: 297-302. (Pubitemid 30459588)
16. World Health Organization, 2010. Guidelines for the Treatment of Malaria. Geneva: World Health Organization.
17. ter Kuile FO, Nosten F, Luxemburger C, Kyle D, Teja-Isavatharm P, Phaipun L, Price R, Chongsuphajaisiddhi T, White NJ, 1995. Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3,673 patients. Bull World Health Organ 73: 631-642. (Pubitemid 26020629)
18. Price R, van Vugt M, Phaipun L, Luxemburger C, Simpson J, McGready R, ter Kuile F, Kham A, Chongsuphajaisiddhi T, White NJ, Nosten F, 1999. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg 60: 547-555. (Pubitemid 29233109)
19. Agomo PU, Meremikwu MM, Watila IM, Omalu IJ, Odey FA, Oguche S, Ezeiru VI, Aina OO, 2008. Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria. Malar J 7: 172.
20. Fraser B, 2006. Providing medical care in the Peruvian Amazon. Lancet 368: 1408-1409.
21. Quick RE, Vargas R, Moreno D, Mujica O, Beingolea L, Palacios AM, Seminario L, Tauxe RV, 1993. Epidemic cholera in the Amazon: the challenge of preventing death. Am J Trop Med Hyg 48: 597-602. (Pubitemid 23187187)
22. Zhou Z, Griffing SM, de Oliveira AM, McCollum AM, Quezada WM, Arrospide N, Escalante AA, Udhayakumar V, 2008. Decline in sulfadoxine-pyrimethamine- resistant alleles after change in drug policy in the Amazon region of Peru. Antimicrob Agents Chemother 52: 739-741. (Pubitemid 351170855)
23. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimde AA, Kouriba B, Taylor TE, Plowe CV, 2003. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis 187: 1870-1875. (Pubitemid 36724485)
24. Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV, 2006. Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 355: 1959-1966. (Pubitemid 44708015)
25. Lim P, Alker AP, Khim N, Shah NK, Incardona S, Doung S, Yi P, Bouth DM, Bouchier C, Puijalon OM, Meshnick SR, Wongsrichanalai C, Fandeur T, Le Bras J, Ringwald P, Ariey F, 2009. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar J 8: 11.
26. Vestergaard LS, Ringwald P, 2007. Responding to the challenge of antimalarial drug resistance by routine monitoring to update national malaria treatment policies. Am J Trop Med Hyg 77: 153-159.
27. Kachur SP, Khatib RA, Kaizer E, Fox SS, Abdulla SM, Bloland PB, 2004. Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania. Am J Trop Med Hyg 71: 715-722. (Pubitemid 40075619)
28. Krause G, Sauerborn R, 2000. Comprehensive community effectiveness of health care. A study of malaria treatment in children and adults in rural Burkina Faso. Ann Trop Paediatr 20: 273-282.
29. Dharia NV, Plouffe D, Bopp SE, Gonzalez-Paez GE, Lucas C, Salas C, Soberon V, Bursulaya B, Kochel TJ, Bacon DJ, Winzeler EA, 2010. Genome scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasites. Genome Res 20: 1534-1544